The deal sees Matrix take a minority holding in RDL, which serves the pharmaceutical, business intelligence and IT sectors.

Iain Livingston, an operating partner at Matrix, will become RDL’s chairman.

Matrix partner Jonathan Gregory says the pharmaceutical and business intelligence jobs markets have seen strong recent growth and he expects the upward trend to continue as European economies rebound from the recession.

Before the management buy-out, RDL had been privately held by the company’s two founders.